Barclays raised the firm’s price target on Synovus (SNV) to $70 from $65 and keeps an Overweight rating on the shares. The firm adjusted targets in the mid-cap bank group as part of its 2026 outlook. More differentiation in loan growth and book value expansion is expected within the group next year, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV:
